Literature DB >> 20383178

HDAC4 inhibits the transcriptional activation of mda-7/IL-24 induced by Sp1.

Lina Pan1, Hong Pan, Hao Jiang, Juan Du, Xiuli Wang, Baiqu Huang, Jun Lu.   

Abstract

Melanoma differentiation-associated gene/interleukin-24 (mda-7/IL-24) is a cytokine that can activate monocytes and T helper 2 cells. The expression of mda-7/IL-24 gradually fades with the progression of melanoma, and it is undetectable at the metastatic stage. Ectopic expression of mda-7/IL-24 selectively suppresses growth and induces apoptosis in cancer cells with little harm to normal cells. However, the transcriptional regulation of the mda-7/IL-24 gene has not been extensively studied. In this study, we show that the expression of mda-7/IL-24 was upregulated by the histone deacetylase (HDAC) inhibitors trichostatin A (TSA) and sodium butyrate (NaBu), whereas it was downregulated by HDAC4. We also found that the histone acetylation level and the binding of the transcriptional factor Sp1 to the mad-7 promoter were reduced upon HDAC4 treatment. Moreover, the HDAC inhibitor TSA induced histone hyperacetylation and stimulated Sp1 binding to the mda-7/IL-24 promoter, which in turn enhanced the expression of mda-7/IL-24. Therefore, we conclude that histone acetylation modification plays an important role in the regulation of mda-7/IL-24 and that the transcription factor Sp1 participates in this process.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20383178      PMCID: PMC4002910          DOI: 10.1038/cmi.2010.12

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  12 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Down-regulated melanoma differentiation associated gene (mda-7) expression in human melanomas.

Authors:  S Ekmekcioglu; J Ellerhorst; A M Mhashilkar; A A Sahin; C M Read; V G Prieto; S Chada; E A Grimm
Journal:  Int J Cancer       Date:  2001-10-01       Impact factor: 7.396

Review 3.  The family of IL-10-related cytokines and their receptors: related, but to what extent?

Authors:  Sergei V Kotenko
Journal:  Cytokine Growth Factor Rev       Date:  2002-06       Impact factor: 7.638

Review 4.  MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine.

Authors:  Moira Sauane; Rahul V Gopalkrishnan; Devanand Sarkar; Zao Zhong Su; Irina V Lebedeva; Paul Dent; Sidney Pestka; Paul B Fisher
Journal:  Cytokine Growth Factor Rev       Date:  2003-02       Impact factor: 7.638

5.  Melanoma differentiation associated gene-7 (mda-7): a novel anti-tumor gene for cancer gene therapy.

Authors:  A M Mhashilkar; R D Schrock; M Hindi; J Liao; K Sieger; F Kourouma; X H Zou-Yang; E Onishi; O Takh; T S Vedvick; G Fanger; L Stewart; G J Watson; D Snary; P B Fisher; T Saeki; J A Roth; R Ramesh; S Chada
Journal:  Mol Med       Date:  2001-04       Impact factor: 6.354

6.  Regulation of mda-7 gene expression during human melanoma differentiation.

Authors:  M T Madireddi; P Dent; P B Fisher
Journal:  Oncogene       Date:  2000-03-02       Impact factor: 9.867

7.  AP-1 and C/EBP transcription factors contribute to mda-7 gene promoter activity during human melanoma differentiation.

Authors:  M T Madireddi; P Dent; P B Fisher
Journal:  J Cell Physiol       Date:  2000-10       Impact factor: 6.384

8.  HDAC4 represses p21(WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism.

Authors:  D Mottet; S Pirotte; V Lamour; M Hagedorn; S Javerzat; A Bikfalvi; A Bellahcène; E Verdin; V Castronovo
Journal:  Oncogene       Date:  2008-10-13       Impact factor: 9.867

9.  The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24.

Authors:  Eva G Caudell; John B Mumm; Nancy Poindexter; Suhendan Ekmekcioglu; Abner M Mhashilkar; Xiaohong Helena Yang; Mark W Retter; Paul Hill; Sunil Chada; Elizabeth A Grimm
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

Review 10.  MDA-7/IL-24 is a unique cytokine--tumor suppressor in the IL-10 family.

Authors:  Sunil Chada; R Bryan Sutton; Suhendan Ekmekcioglu; Julie Ellerhorst; John B Mumm; Wolfgang W Leitner; Heng-Yin Yang; Aysegul A Sahin; Kelly K Hunt; Kerry L Fuson; Nancy Poìndexter; Jack A Roth; Rajagopal Ramesh; Elizabeth A Grimm; Abner M Mhashilkar
Journal:  Int Immunopharmacol       Date:  2004-05       Impact factor: 4.932

View more
  9 in total

1.  Common genetic variants related to genomic integrity and risk of papillary thyroid cancer.

Authors:  Gila Neta; Alina V Brenner; Erich M Sturgis; Ruth M Pfeiffer; Amy A Hutchinson; Briseis Aschebrook-Kilfoy; Meredith Yeager; Li Xu; William Wheeler; Michael Abend; Elaine Ron; Margaret A Tucker; Stephen J Chanock; Alice J Sigurdson
Journal:  Carcinogenesis       Date:  2011-06-03       Impact factor: 4.944

2.  Inhibition of NR4A1 Promotes ROS Accumulation and IL24-Dependent Growth Arrest in Rhabdomyosarcoma.

Authors:  Erik Hedrick; Kumaravel Mohankumar; Alexandra Lacey; Stephen Safe
Journal:  Mol Cancer Res       Date:  2019-08-28       Impact factor: 5.852

3.  A novel function of RNAs arising from the long terminal repeat of human endogenous retrovirus 9 in cell cycle arrest.

Authors:  Lai Xu; Abdel G Elkahloun; Fabio Candotti; Andrzej Grajkowski; Serge L Beaucage; Emanuel F Petricoin; Valerie Calvert; Hartmut Juhl; Frederick Mills; Karen Mason; Neal Shastri; Josh Chik; Cynthia Xu; Amy S Rosenberg
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

4.  The antimelanoma activity of the histone deacetylase inhibitor panobinostat (LBH589) is mediated by direct tumor cytotoxicity and increased tumor immunogenicity.

Authors:  David M Woods; Karrune Woan; Fengdong Cheng; Hongwei Wang; Patricio Perez-Villarroel; Calvin Lee; Maritza Lienlaf; Peter Atadja; Edward Seto; Jeffrey Weber; Eduardo M Sotomayor; Alejandro Villagra
Journal:  Melanoma Res       Date:  2013-10       Impact factor: 3.599

5.  Molecular Mechanisms Governing IL-24 Gene Expression.

Authors:  Anupama Sahoo; Sin-Hyeog Im
Journal:  Immune Netw       Date:  2012-02-29       Impact factor: 6.303

Review 6.  Histone Modifications, Modifiers and Readers in Melanoma Resistance to Targeted and Immune Therapy.

Authors:  Stuart J Gallagher; Jessamy C Tiffen; Peter Hersey
Journal:  Cancers (Basel)       Date:  2015-09-25       Impact factor: 6.639

7.  Allyl isothiocyanate regulates lysine acetylation and methylation marks in an experimental model of malignant melanoma.

Authors:  Melina Mitsiogianni; Theodora Mantso; Dimitrios T Trafalis; H P Vasantha Rupasinghe; Vasilis Zoumpourlis; Rodrigo Franco; Sotiris Botaitis; Aglaia Pappa; Mihalis I Panayiotidis
Journal:  Eur J Nutr       Date:  2019-02-14       Impact factor: 5.614

Review 8.  Insights into the Mechanisms of Action of MDA-7/IL-24: A Ubiquitous Cancer-Suppressing Protein.

Authors:  Jinkal Modi; Abhishek Roy; Anjan K Pradhan; Amit Kumar; Sarmistha Talukdar; Praveen Bhoopathi; Santanu Maji; Padmanabhan Mannangatti; Daniel Sanchez De La Rosa; Jiong Li; Chunqing Guo; Mark A Subler; Jolene J Windle; Webster K Cavenee; Devanand Sarkar; Xiang-Yang Wang; Swadesh K Das; Luni Emdad; Paul B Fisher
Journal:  Int J Mol Sci       Date:  2021-12-22       Impact factor: 6.208

9.  Sulforaphane and iberin are potent epigenetic modulators of histone acetylation and methylation in malignant melanoma.

Authors:  Melina Mitsiogianni; Dimitrios T Trafalis; Rodrigo Franco; Vasilis Zoumpourlis; Aglaia Pappa; Mihalis I Panayiotidis
Journal:  Eur J Nutr       Date:  2020-03-25       Impact factor: 5.614

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.